Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?

To: Jon K. who wrote (123)	1/25/1999 9:26:00 AM
From: OFW	Read Replies (2) \| Respond to of 370

Looking like a strong open for both VION and VIONZ. (eom)

To: Jon K. who wrote (123)	1/25/1999 9:48:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 370

The "big news"? Chuckle. VION always has some "big news" coming, it seems. I've given my opinion of VION many times. They have already changed names twice, once since public. Lots of hype about projects that were obviously going nowhere..... the game was like those that Paramount Capital plays in biotech.... throw a wide net, and hope that you catch a live project. TAPPET...... it's new, fun. For a long time, I criticized it because they were talking about Salmonella that was not "detoxified". It was apparent that the talk was largely bull. But, they have now addressed that problem and TAPPET looks like fun.